<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35551579</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-2630</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>12</Day>
            </PubDate>
          </JournalIssue>
          <Title>International ophthalmology</Title>
          <ISOAbbreviation>Int Ophthalmol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Thicknesses of the retinal layers in patients with Graves' disease with or without orbitopathy.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10792-022-02339-w</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Graves' orbitopathy (GO) is an inflammatory process that may involve the ocular surface, orbital fat, extraocular muscles, and optic nerves in patients with Graves' disease (GD). We aimed to compare thicknesses of retinal layers in patients with GD with and without GO.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">One hundred seven patients with GD [23 with GO (Group 1), 84 without GO (Group 2)] and eighteen volunteers (Group 3) were enrolled. The spectral-domain optical coherence tomography (SD-OCT) was used for ophthalmologic evaluation. Seven retinal layers including retinal nerve fibre layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), retinal pigment epithelium (RPE) were assessed. The thicknesses of layers were compared in groups.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The median GCL thickness values in groups 1, 2, and 3 were 14 µm, 15 µm, and 17.5 µm, respectively (p = 0.02). The median IPL thickness was 20 µm in group 1, 21 µm in group 2, and 22 µm in group 3 (p = 0.038). The median RPE thickness values in groups 1, 2, and 3 were 16 µm, 17 µm, and 18.5 µm, respectively (p = 0.001). GCL in group 1 was thinner than in group 3 (p = 0.02), while similar in groups 2 and 3 (p = 0.06). IPL in group 1 was thinner than in group 3 (p = 0.035), while similar in groups 2 and 3 (p = 0.13). RPE in groups 1 and 2 was thinner than in group 3 (p = 0.009, p = 0.001, respectively), while it was similar in groups 1 and 2 (p = 0.93). RNLF, INL, OPL, ONL were similar in all three (p &gt; 0.05 for each).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Ganglion cell layer and IPL were thinner in patients with GO than in healthy controls, while both were similar in patients without GO and healthy controls. RPE was thinner in all Graves patients than in healthy controls. Early detection of changes in retinal layers of GD may guide the physician to prevent significant vision problems.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ogmen</LastName>
            <ForeName>Berna Evranos</ForeName>
            <Initials>BE</Initials>
            <Identifier Source="ORCID">0000-0002-1848-888X</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Ankara Bilkent City Hospital, Department of Endocrinology and Metabolism, Ankara Yildirim Beyazit University, Üniversiteler Mh., Bilkent Blv., 06800, Ankara, Turkey. evranosberna@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ugurlu</LastName>
            <ForeName>Nagihan</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Ankara Bilkent City Hospital, Department of Ophthalmology, Ankara Yildirim Beyazit University, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bilginer</LastName>
            <ForeName>Muhammet Cuneyt</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Department of Endocrinology and Metabolism, Karadeniz Technical University, Trabzon, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Polat</LastName>
            <ForeName>Sefika Burcak</ForeName>
            <Initials>SB</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Ankara Bilkent City Hospital, Department of Endocrinology and Metabolism, Ankara Yildirim Beyazit University, Üniversiteler Mh., Bilkent Blv., 06800, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Genc</LastName>
            <ForeName>Birgul</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Health Sciences Institute, Ankara Bilkent City Hospital, Department of Endocrinology and Metabolism, Ankara Yildirim Beyazit University, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ersoy</LastName>
            <ForeName>Reyhan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Ankara Bilkent City Hospital, Department of Endocrinology and Metabolism, Ankara Yildirim Beyazit University, Üniversiteler Mh., Bilkent Blv., 06800, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cakir</LastName>
            <ForeName>Bekir</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Ankara Bilkent City Hospital, Department of Endocrinology and Metabolism, Ankara Yildirim Beyazit University, Üniversiteler Mh., Bilkent Blv., 06800, Ankara, Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Int Ophthalmol</MedlineTA>
        <NlmUniqueID>7904294</NlmUniqueID>
        <ISSNLinking>0165-5701</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ganglion cell layer</Keyword>
        <Keyword MajorTopicYN="N">Graves’ disease</Keyword>
        <Keyword MajorTopicYN="N">Graves’ ophthalmopathy</Keyword>
        <Keyword MajorTopicYN="N">Inner plexiform layer</Keyword>
        <Keyword MajorTopicYN="N">Optical coherence tomography</Keyword>
        <Keyword MajorTopicYN="N">Retinal layers</Keyword>
        <Keyword MajorTopicYN="N">Retinal nerve fibre layer</Keyword>
        <Keyword MajorTopicYN="N">Retinal pigment epithelium</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>13</Hour>
          <Minute>40</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35551579</ArticleId>
        <ArticleId IdType="doi">10.1007/s10792-022-02339-w</ArticleId>
        <ArticleId IdType="pii">10.1007/s10792-022-02339-w</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bruscolini A, Abbouda A, Locuratolo N, Restivo L, Trimboli P, Romanelli F (2015) Dry eye syndrome in non-exophthalmic graves’ disease. Semin Ophthalmol 30(5–6):372–376. https://doi.org/10.3109/08820538.2013.874491</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08820538.2013.874491</ArticleId>
            <ArticleId IdType="pubmed">24460515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith TJ (2010) Pathogenesis of graves’ orbitopathy: a 2010 update. J Endocrinol Invest 33(6):414–421. https://doi.org/10.1007/BF03346614</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF03346614</ArticleId>
            <ArticleId IdType="pubmed">20631493</ArticleId>
            <ArticleId IdType="pmc">6779038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brent GA (2008) Clinical practice. Graves’ disease. N Engl J Med 358(24):2594–2605. https://doi.org/10.1056/NEJMcp0801880</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMcp0801880</ArticleId>
            <ArticleId IdType="pubmed">18550875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahn RS (2010) Graves’ ophthalmopathy. N Engl J Med 362(8):726–738. https://doi.org/10.1056/NEJMra0905750</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra0905750</ArticleId>
            <ArticleId IdType="pubmed">20181974</ArticleId>
            <ArticleId IdType="pmc">3902010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiromatsu Y, Eguchi H, Tani J, Kasaoka M, Teshima Y (2014) Graves’ ophthalmopathy: epidemiology and natural history. Intern Med 53(5):353–360. https://doi.org/10.2169/internalmedicine.53.1518</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.53.1518</ArticleId>
            <ArticleId IdType="pubmed">24583420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burlacu M, Daumerie C (2017) Epidemiology. Graves’ orbitopathy: a multidisciplinary approach—questions and answers. Karger, Basel</Citation>
        </Reference>
        <Reference>
          <Citation>Smith TJ, Hegedus L (2016) Graves’ disease. N Engl J Med 375(16):1552–1565. https://doi.org/10.1056/NEJMra1510030</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1510030</ArticleId>
            <ArticleId IdType="pubmed">27797318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perros P, Dayan CM, Dickinson AJ, Ezra D, Estcourt S, Foley P, Hickey J, Lazarus JH, MacEwen CJ, McLaren J, Rose GE, Uddin J, Vaidya B (2015) Management of patients with Graves’ orbitopathy: initial assessment, management outside specialised centres and referral pathways. Clin Med (Lond) 15(2):173–178. https://doi.org/10.7861/clinmedicine.15-2-173</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7861/clinmedicine.15-2-173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frueh BR, Musch DC, Garber FW (1986) Lid retraction and levator aponeurosis defects in Graves’ eye disease. Ophthalmic Surg 17(4):216–220</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3754942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McKeag D, Lane C, Lazarus JH, Baldeschi L, Boboridis K, Dickinson AJ, Hullo AI, Kahaly G, Krassas G, Marcocci C, Marino M, Mourits MP, Nardi M, Neoh C, Orgiazzi J, Perros P, Pinchera A, Pitz S, Prummel MF, Sartini MS, Wiersinga WM (2007) Clinical features of dysthyroid optic neuropathy: a European Group on Graves’ Orbitopathy (EUGOGO) survey. Br J Ophthalmol 91(4):455–458. https://doi.org/10.1136/bjo.2006.094607</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjo.2006.094607</ArticleId>
            <ArticleId IdType="pubmed">17035276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hollenberg A, Wiersinga WM (2019) Hyperthyroid disorders. In: Melmed S (ed) Williams textbook of endocrinology, 14th edn. Elsevier, Amsterdam, pp 364–403</Citation>
        </Reference>
        <Reference>
          <Citation>Waheed NK, Kashani AH, Amorim CA, Filho G, Duker JS, Rosenfeld PJ (2018) Optical coherence tomography. In: Schachat AP (ed) Ryan’s retina, 6th edn. Elsevier, Amsterdam, pp 77–119</Citation>
        </Reference>
        <Reference>
          <Citation>Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA et al (1991) Optical coherence tomography. Science 254(5035):1178–1181</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1957169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drexler W, Fujimoto JG (2008) State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res 27(1):45–88. https://doi.org/10.1016/j.preteyeres.2007.07.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.preteyeres.2007.07.005</ArticleId>
            <ArticleId IdType="pubmed">18036865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun JK, Lin MM, Lammer J, Prager S, Sarangi R, Silva PS, Aiello LP (2014) Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol 132(11):1309–1316. https://doi.org/10.1001/jamaophthalmol.2014.2350</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaophthalmol.2014.2350</ArticleId>
            <ArticleId IdType="pubmed">25058813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Invernizzi A, Pellegrini M, Acquistapace A, Benatti E, Erba S, Cozzi M, Cigada M, Viola F, Gillies M, Staurenghi G (2018) Normative data for retinal-layer thickness maps generated by spectral-domain OCT in a white population. Ophthalmol Retina 2(8):808–815. https://doi.org/10.1016/j.oret.2017.12.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.oret.2017.12.012</ArticleId>
            <ArticleId IdType="pubmed">31047534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staurenghi G, Sadda S, Chakravarthy U, Spaide RF, International Nomenclature for Optical Coherence Tomography P (2014) Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN*OCT consensus. Ophthalmology 121(8):1572–1578. https://doi.org/10.1016/j.ophtha.2014.02.023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ophtha.2014.02.023</ArticleId>
            <ArticleId IdType="pubmed">24755005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>(1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 103(12):1796–1806</Citation>
        </Reference>
        <Reference>
          <Citation>Werner SC (1977) Modification of the classification of the eye changes of Graves’ disease. Am J Ophthalmol 83(5):725–727. https://doi.org/10.1016/0002-9394(77)90140-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-9394(77)90140-4</ArticleId>
            <ArticleId IdType="pubmed">577380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM, European Group on Graves O (2016) The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the Management of Graves’ Orbitopathy. Eur Thyroid J 5(1):9–26. https://doi.org/10.1159/000443828</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000443828</ArticleId>
            <ArticleId IdType="pubmed">27099835</ArticleId>
            <ArticleId IdType="pmc">4836120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wessely K (1918) Discussion of Hertel E WeitererBetragzurLehre von Augendruck. Der Dtsch Ophthlmol Ges 41:80–81</Citation>
        </Reference>
        <Reference>
          <Citation>Braley AE (1953) Malignant exophthalmos. Am J Ophthalmol 36(9):1286–1290. https://doi.org/10.1016/0002-9394(53)92299-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-9394(53)92299-5</ArticleId>
            <ArticleId IdType="pubmed">13080407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyons DE (1971) Postural changes in IOP in dysthyroid exophthalmos. Trans Ophthalmol Soc 91:799–803</Citation>
        </Reference>
        <Reference>
          <Citation>Gamblin GT, Harper DG, Galentine P, Buck DR, Chernow B, Eil C (1983) Prevalence of increased intraocular pressure in Graves’ disease—evidence of frequent subclinical ophthalmopathy. N Engl J Med 308(8):420–424. https://doi.org/10.1056/NEJM198302243080803</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM198302243080803</ArticleId>
            <ArticleId IdType="pubmed">6687400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nardi M, Bartolomei MP, Romani A, Barca L (1988) Intraocular pressure changes in secondary positions of gaze in normal subjects and in restrictive ocular motility disorders. Graefes Arch Clin Exp Ophthalmol 226(1):8–10. https://doi.org/10.1007/BF02172708</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF02172708</ArticleId>
            <ArticleId IdType="pubmed">3342982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fishman DR, Benes SC (1991) Upgaze intraocular pressure changes and strabismus in Graves’ ophthalmopathy. J Clin Neuroophthalmol 11(3):162–165</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1836798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalmann R, Mourits MP (1998) Prevalence and management of elevated intraocular pressure in patients with Graves’ orbitopathy. Br J Ophthalmol 82(7):754–757. https://doi.org/10.1136/bjo.82.7.754</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjo.82.7.754</ArticleId>
            <ArticleId IdType="pubmed">9924366</ArticleId>
            <ArticleId IdType="pmc">1722671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tu S, Li K, Ding X, Hu D, Li K, Ge J (2019) Relationship between intraocular pressure and retinal nerve fibre thickness loss in a monkey model of chronic ocular hypertension. Eye (Lond) 33(12):1833–1841. https://doi.org/10.1038/s41433-019-0484-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41433-019-0484-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cronemberger S, Veloso AC, Scarpelli G, Sasso YC (2018) Relationship between intraocular pressure (IOP) peak and rates of retinal nerve fiber layer (RNFL) loss by spectral-domain optical coherence tomography (SD-OCT). Invest Ophthalmol Vis Sci 59(9):2116–2116</Citation>
        </Reference>
        <Reference>
          <Citation>Casini G, Marino M, Rubino M, Licari S, Covello G, Mazzi B, Ionni I, Rocchi R, Sframeli AT, Figus M, Loiudice P (2020) Retinal, choroidal and optic disc analysis in patients with Graves’ disease with or without orbitopathy. Int Ophthalmol 40(9):2129–2137. https://doi.org/10.1007/s10792-020-01392-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10792-020-01392-7</ArticleId>
            <ArticleId IdType="pubmed">32358735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sayin O, Yeter V, Ariturk N (2016) Optic disc, macula, and retinal nerve fiber layer measurements obtained by OCT in thyroid-associated ophthalmopathy. J Ophthalmol 2016:9452687. https://doi.org/10.1155/2016/9452687</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2016/9452687</ArticleId>
            <ArticleId IdType="pubmed">27493796</ArticleId>
            <ArticleId IdType="pmc">4967470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forte R, Bonavolonta P, Vassallo P (2010) Evaluation of retinal nerve fiber layer with optic nerve tracking optical coherence tomography in thyroid-associated orbitopathy. Ophthalmologica 224(2):116–121. https://doi.org/10.1159/000235925</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000235925</ArticleId>
            <ArticleId IdType="pubmed">19729984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurt MM, Akpolat C, Evliyaoglu F, Yilmaz M, Ordulu F (2021) Evaluation of retinal neurodegeneration and choroidal thickness in patients with inactive graves’ ophthalmopathy. Klin Monbl Augenheilkd 238(7):797–802. https://doi.org/10.1055/a-1275-0703</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/a-1275-0703</ArticleId>
            <ArticleId IdType="pubmed">33733445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blum Meirovitch S, Leibovitch I, Kesler A, Varssano D, Rosenblatt A, Neudorfer M (2017) Retina and nerve fiber layer thickness in eyes with thyroid-associated ophthalmopathy. Isr Med Assoc J 19(5):277–281</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28513113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang YH, Ma J, Li H, Xu HY, Gan LY, Zhang X, Wang XQ, Zhong Y (2020) Peripapillary and macular vessel density in eyes with different phases of thyroid-associated ophthalmopathy. Zhonghua Yan Ke Za Zhi 56(11):824–831. https://doi.org/10.3760/cma.j.cn112142-20191115-00574</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3760/cma.j.cn112142-20191115-00574</ArticleId>
            <ArticleId IdType="pubmed">33152840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romano MR, Cennamo G, Breve MA, Piedepalumbo M, Iovino C, Velotti N, Cennamo G (2017) Optic nerve compression: the role of the lamina cribrosa and translaminar pressure. Int J Ophthalmol 10(12):1883–1888. https://doi.org/10.18240/ijo.2017.12.15</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18240/ijo.2017.12.15</ArticleId>
            <ArticleId IdType="pubmed">29259908</ArticleId>
            <ArticleId IdType="pmc">5733517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J, Lee YJ, Won JY (2021) Molecular mechanisms of retinal pigment epithelium dysfunction in age-related macular degeneration. Int J Mol Sci. https://doi.org/10.3390/ijms222212298</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms222212298</ArticleId>
            <ArticleId IdType="pubmed">35008883</ArticleId>
            <ArticleId IdType="pmc">8745517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106-116. https://doi.org/10.1016/S2214-109X(13)70145-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2214-109X(13)70145-1</ArticleId>
            <ArticleId IdType="pubmed">25104651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaker L, Buitendijk GH, Dehghan A, Medici M, Hofman A, Vingerling JR, Franco OH, Klaver CC, Peeters RP (2015) Thyroid function and age-related macular degeneration: a prospective population-based cohort study—the Rotterdam Study. BMC Med 13:94. https://doi.org/10.1186/s12916-015-0329-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12916-015-0329-0</ArticleId>
            <ArticleId IdType="pubmed">25903050</ArticleId>
            <ArticleId IdType="pmc">4407352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gopinath B, Liew G, Kifley A, Mitchell P (2016) Thyroid dysfunction and ten-year incidence of age-related macular degeneration. Invest Ophthalmol Vis Sci 57(13):5273–5277. https://doi.org/10.1167/iovs.16-19735</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.16-19735</ArticleId>
            <ArticleId IdType="pubmed">27716857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Q, Li Y, Cheng Y, Qu Y (2018) Assessment of the effect of age on macular layer thickness in a healthy Chinese cohort using spectral-domain optical coherence tomography. BMC Ophthalmol 18(1):169. https://doi.org/10.1186/s12886-018-0842-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12886-018-0842-y</ArticleId>
            <ArticleId IdType="pubmed">29996804</ArticleId>
            <ArticleId IdType="pmc">6042244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Won JY, Kim SE, Park YH (2016) Effect of age and sex on retinal layer thickness and volume in normal eyes. Medicine (Baltimore) 95(46):e5441. https://doi.org/10.1097/MD.0000000000005441</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000005441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ooto S, Hangai M, Tomidokoro A, Saito H, Araie M, Otani T, Kishi S, Matsushita K, Maeda N, Shirakashi M, Abe H, Ohkubo S, Sugiyama K, Iwase A, Yoshimura N (2011) Effects of age, sex, and axial length on the three-dimensional profile of normal macular layer structures. Invest Ophthalmol Vis Sci 52(12):8769–8779. https://doi.org/10.1167/iovs.11-8388</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.11-8388</ArticleId>
            <ArticleId IdType="pubmed">21989721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chua J, Tham YC, Tan B, Devarajan K, Schwarzhans F, Gan A, Wong D, Cheung CY, Majithia S, Thakur S, Fischer G, Vass C, Cheng CY, Schmetterer L (2019) Age-related changes of individual macular retinal layers among Asians. Sci Rep 9(1):20352. https://doi.org/10.1038/s41598-019-56996-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-56996-6</ArticleId>
            <ArticleId IdType="pubmed">31889143</ArticleId>
            <ArticleId IdType="pmc">6937292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mugdha K, Kaur A, Sinha N, Saxena S (2016) Evaluation of retinal nerve fiber layer thickness profile in thyroid ophthalmopathy without optic nerve dysfunction. Int J Ophthalmol 9(11):1634–1637. https://doi.org/10.18240/ijo.2016.11.16</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18240/ijo.2016.11.16</ArticleId>
            <ArticleId IdType="pubmed">27990368</ArticleId>
            <ArticleId IdType="pmc">5145093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JH, Park SH, Koh DG, Suh BK (2014) Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves’ ophthalmopathy. World J Pediatr 10(2):155–159. https://doi.org/10.1007/s12519-014-0476-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12519-014-0476-y</ArticleId>
            <ArticleId IdType="pubmed">24668239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright-Pascoe R, Smikle MF, Barton EN, James OB (1999) Limited usefulness of antithyroperoxidase and antithyroglobulin assays in Jamaicans with Graves’ disease. Hum Antibodies 9(3):161–164</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/HAB-1999-9305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khoo DH, Ho SC, Seah LL, Fong KS, Tai ES, Chee SP, Eng PH, Aw SE, Fok AC (1999) The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves’ disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 9(12):1175–1180. https://doi.org/10.1089/thy.1999.9.1175</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/thy.1999.9.1175</ArticleId>
            <ArticleId IdType="pubmed">10646655</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
